Publications

5891 Results

S0204: melphalan (MEL)-based tandem autotransplants (TAT) for multiple myeloma (MM) with thalidomide/dexamethasone (TD) induction and thalidomide/prednisone (TP) maintenance: a phase II trial of the Southwest Oncology Group

Authors
MA Hussein;AJ Jakubowiak;V Bolejack;J Zonder;J Crowley;B Barlogie
Journal / Conference
Blood 108:#3088
Year
2006
Research Committee(s)
Myeloma
Study Number(s)
S0204

Local perspective of the impact of the HIPAA privacy rule on research

Authors
MS Wolf;CL Bennett
Journal / Conference
Cancer 106(2):474-479
Year
2006
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

Authors
JA Zonder;B Barlogie;BGM Durie;J McCoy;J Crowley;MA Hussein
Journal / Conference
Blood (Letter to the Editor)
Year
2006
Research Committee(s)
Myeloma
Study Number(s)
S0232

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Authors
G Cairncross;B Berkey;E Shaw;R Jenkins;B Scheithauer;D Brachman;J Buckner;K Fink;L Souhami;N Laperierre;M Mehta;W Curran
Journal / Conference
Journal of Clinical Oncology 24(18):2707-2714
Year
2006
Research Committee(s)
Brain
Study Number(s)
SWOG-9402

Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: A Gynecologic Oncology Group Study

Authors
CL Trimble;J Kauderer;R Zaino;S Silverberg;PC Lim;JJ Burke;DS Alberts;J Curtin
Journal / Conference
Cancer 106(4):812-819
Year
2006
Research Committee(s)
Gynecologic
Study Number(s)
G0167

Targeting events in melanoma carcinogenesis for the prevention of melanoma

Authors
CD Lao;MF Demierre;VK Sondak
Journal / Conference
Expert Reviews in Anticancer Therapy 6(11):1559-1568
Year
2006
Research Committee(s)
Melanoma

Adjuvant radiotherapy (RT) and trastuzumab in stage I-IIA breast cancer: toxicity data from North Central Cancer Treatment Group phase III trial N9831

Authors
MY Halyard;TM Pisansky;LJ Solin;LB Marks;LJ Pierce;A Dueck;EA Perez
Journal / Conference
Journal of Clinical Oncology 24 (18S):523
Year
2006
Research Committee(s)
Breast
Study Number(s)
N9831

Relapse of acute promyelocytic leukemia with PML-RARa mutant subclones independent of proximate all-trans retinoic acid selection pressure

Authors
RE Gallagher;EL Schachter-Tokarz;DC Zhou;W Ding;SH Kim;BJ Sankoorikal;W Bi;KL Livak;JL Slack;CL Willman
Journal / Conference
Leukemia 20:556-562
Year
2006
Research Committee(s)
Leukemia
Study Number(s)
C9710

Frequent PML-RARa mutations in relapse patients on acute promyelocytic leukemia (APL) intergroup Phase III trial C9710

Authors
RE Gallagher;EL Schachter-Tokarz;BK Moser;D Sher;E Paietta;MS Tallman;C Bloomfield;B Powell;RA Larson;FR Appelbaum;CL Willman;RC Harvey
Journal / Conference
Blood 108:#2342
Year
2006
Research Committee(s)
Leukemia
Study Number(s)
C9710

Outcome of African American women with breast cancer in cooperative group clinical trials

Authors
JM Unger;S Green;KS Albain
Journal / Conference
Breast Cancer in Women of African Descent, Ch. 11, pp 267-295, C. Williams et al. (eds.), Springer, printed in Netherlands
Year
2006
Research Committee(s)
Breast
Study Number(s)
SWOG-7436, SWOG-7827, SWOG-8313 (EST 5186), SWOG-8814, SWOG-8897